Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia JOURNAL OF NEUROIMMUNOLOGY 2020
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients AIDS 2020
Is previous influenza-like illness a potential Trojan horse for COVID-19? CRITICAL CARE 2020
Covid-19 and the role of smoking. The protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly) ACTA BIOMEDICA 2020
Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19 AMERICAN JOURNAL OF OTOLARYNGOLOGY 2020
Interplay between male testosterone levels and the risk for subsequent invasive respiratory assistance among COVID-19 patients at hospital admission ENDOCRINE 2020
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection. A case report MEDICINE 2020
Retinal involvement and ocular findings in COVID-19 pneumonia patients SCIENTIFIC REPORTS 2020
Ozone as adjuvant support in the treatment of covid-19: a preliminary report of probiozovid trial JOURNAL OF MEDICAL VIROLOGY 2020
Antimicrobial essential oil formulation: chitosan coated nanoemulsions for nose to brain delivery PHARMACEUTICS 2020
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM 2020
Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2020
Missed opportunities of flu vaccination in Italian target categories. Insights from the online epicovid 19 survey VACCINES 2020
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature INFECTION 2020
Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY study) CLINICAL INFECTIOUS DISEASES 2020
Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial METABOLITES 2020
Major reduction of NKT cells in patients with severe COVID-19 pneumonia CLINICAL IMMUNOLOGY 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization LE INFEZIONI IN MEDICINA 2020
Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: A prospective clinical experience ANTIBIOTICS 2020

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma